Status and phase
Conditions
Treatments
About
This study is an open-label, international, multi-center, Phase 2 study in adult patients with recurrent, locally-advanced or metastatic solid tumors, which harbor the NRG1 gene fusion.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
To be eligible for participation in the study, patients must meet the following inclusion criteria:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
54 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal